Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Claritev (CTEV) EBT (2019 - 2025)

Claritev has reported EBT over the past 7 years, most recently at -$106.9 million for Q4 2025.

  • Quarterly results put EBT at -$106.9 million for Q4 2025, up 42.55% from a year ago — trailing twelve months through Dec 2025 was -$805.1 million (up 32.81% YoY), and the annual figure for FY2025 was -$373.1 million, up 78.93%.
  • EBT for Q4 2025 was -$106.9 million at Claritev, down from -$93.4 million in the prior quarter.
  • Over the last five years, EBT for CTEV hit a ceiling of $97.8 million in Q3 2021 and a floor of -$648.0 million in Q4 2022.
  • Median EBT over the past 5 years was -$31.8 million (2023), compared with a mean of -$111.7 million.
  • Biggest five-year swings in EBT: surged 1898.2% in 2021 and later plummeted 29630.23% in 2024.
  • Claritev's EBT stood at $34.5 million in 2021, then plummeted by 1978.45% to -$648.0 million in 2022, then surged by 95.1% to -$31.8 million in 2023, then plummeted by 485.7% to -$186.1 million in 2024, then surged by 42.55% to -$106.9 million in 2025.
  • The last three reported values for EBT were -$106.9 million (Q4 2025), -$93.4 million (Q3 2025), and -$186.1 million (Q4 2024) per Business Quant data.